Literature DB >> 11487175

Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose.

C K Chang1, T K Tso, J T Snook, Y S Huang, R A Lozano, W B Zipf.   

Abstract

The activities of two crucial enzymes of reverse cholesterol transport, cholesterol ester transfer protein (CETP) and lecithin:cholesterol acyltransferase (LCAT), and their relationships with lipid profile and fasting plasma glucose were examined in 35 type 1 diabetic children. The CETP and LCAT activities were significantly lower (p<0.05) in the 4 subjects with normal fasting plasma glucose levels (<6.39 mmol/l) than in the 28 with high plasma glucose levels (CEPT activity, 10.63+/-3.81 vs. 32.18+/-13.94 nmol/ml h; LCAT activity, 25.52+/-4.53 vs. 39.52+/-12.52 nmol/ml h; both p<0.05). The subjects with high plasma glucose levels also had higher total and LDL-cholesterol than those with normal glucose levels. CETP activity was positively correlated with fasting plasma glucose, CETP concentration, LCAT activity, total cholesterol, free cholesterol, LDL-C, and LDL-cholesteryl ester, while negatively correlated with cholesteryl ester to free cholesterol ratio, LDL triglyceride to protein ratio, and LDL triglyceride to cholesteryl ester ratio. LCAT activity was found to positively correlate with CETP activity, total cholesterol, free cholesterol, LDL-C, CETP concentration, and LDL-cholesteryl ester, while it negatively correlated with cholesteryl ester to free cholesterol ratio. The results observed in type 1 diabetic subjects suggest that (1) accelerated LCAT and CETP activities may result in the accumulation of LDL-cholesteryl ester; and (2) fasting plasma glucose may be a major determinant of CETP activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487175     DOI: 10.1007/s005920170027

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  2 in total

1.  The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease.

Authors:  Qiuzhen Lin; Yan Fu; XueYan Zang; Qiming Liu; Ling Liu
Journal:  Front Cardiovasc Med       Date:  2021-06-16

2.  Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.

Authors:  Alina C R Feitosa; Gilson S Feitosa-Filho; Fatima R Freitas; Bernardo L Wajchenberg; Raul C Maranhão
Journal:  Lipids Health Dis       Date:  2013-02-11       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.